JOSH'S STORY
In February of 2021, Josh’s parents noticed he was getting very pale. What was originally thought to...
Read MoreMedulloblastoma (MB) is a highly aggressive embryonic tumour of the cerebellum and the most common malignant brain tumour of childhood (1). Despite a cure rate of approximately 70-75% among children aged ?3 years, MB survivors continue to pay a high price, in terms of long-term adverse sequelae, for cure (2). A well defined neoplastic feature of MB is the genetic modifications of several different components of the Cyclin-dependent kinase (CDK)/Cyclin regulatory complex that plays a vital role in the cell cycle progression and transcriptional control (3-6). These genetic aberrations contribute to MB formation, suggesting that pharmacologic intervention to inhibit the CDKs activity may be a useful chemoprevention or therapeutic strategy for MB patients.
Grant Award – Kidscan Student Placement (2018 – 2019)
Funding Award – £2000.00
Funding Awarded to – Dr Gianpiero Di Leva
Research Location – University of Salford
Lead Researcher – Dr Gianpiero Di Leva
In February of 2021, Josh’s parents noticed he was getting very pale. What was originally thought to...
Read MoreWhat a whopper of a night - Friday 20th May, our ambassador Isla's mum Jill and family hosted...
Read MoreWe want to say a huge thank you to Lee Mossop, former Captain of RFL Salford Red...
Read More